Review article · 2026

Rational modification of PROTACs for tumor-selective protein degradation

Zhongliang Fu, Meichen Pan, Chunrong Yang, Hongwei Hou, Jinghong Li

Advanced Drug Delivery Reviews, 230, 115775 · Published 10 January 2026 · DOI 10.1016/j.addr.2026.115775

View at the publisherCite this paper

In brief

“Rational modification of PROTACs for tumor-selective protein degradation” is a 2026 review article by Zhongliang Fu and 4 co-authors, published in Advanced Drug Delivery Reviews. OpenAlex counts 15 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
15
Most cited in
2026 (15)
Field-weighted impact
6.91
References
224
Authors
5

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Fu, Z., Pan, M., Yang, C., Hou, H., & Li, J. (2026). Rational modification of PROTACs for tumor-selective protein degradation. Advanced Drug Delivery Reviews, 230, 115775. https://doi.org/10.1016/j.addr.2026.115775

MLA 9

Fu, Zhongliang, et al. “Rational modification of PROTACs for tumor-selective protein degradation.” Advanced Drug Delivery Reviews, vol. 230, 2026, p. 115775. https://doi.org/10.1016/j.addr.2026.115775.

Chicago

Fu, Zhongliang, Meichen Pan, Chunrong Yang, Hongwei Hou, and Jinghong Li. 2026. “Rational modification of PROTACs for tumor-selective protein degradation.” Advanced Drug Delivery Reviews 230: 115775. https://doi.org/10.1016/j.addr.2026.115775.

Harvard

Fu, Z. et al. (2026) ‘Rational modification of PROTACs for tumor-selective protein degradation’, Advanced Drug Delivery Reviews, 230, p. 115775. doi:10.1016/j.addr.2026.115775.

IEEE

Z. Fu, M. Pan, C. Yang, H. Hou, and J. Li, “Rational modification of PROTACs for tumor-selective protein degradation,” Advanced Drug Delivery Reviews, vol. 230, p. 115775, 2026, doi: 10.1016/j.addr.2026.115775.

BibTeX

@article{fu2026rational,
  title     = {{Rational modification of PROTACs for tumor-selective protein degradation}},
  author    = {Fu, Zhongliang and Pan, Meichen and Yang, Chunrong and Hou, Hongwei and Li, Jinghong},
  journal   = {Advanced Drug Delivery Reviews},
  year      = {2026},
  volume    = {230},
  pages     = {115775},
  doi       = {10.1016/j.addr.2026.115775},
  url       = {https://doi.org/10.1016/j.addr.2026.115775}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • ubiquitin-proteasome system
  • cancer therapy
  • tumor microenvironment
  • active targeting
  • nanocarriers
  • tissue distribution
  • undruggable proteins

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Fu, Z., Pan, M., Yang, C., Hou, H., & Li, J. (2026). Rational modification of PROTACs for tumor-selective protein degradation. Advanced Drug Delivery Reviews, 230, 115775. https://doi.org/10.1016/j.addr.2026.115775

How many times has this paper been cited?

15 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Zhongliang Fu, Meichen Pan, Chunrong Yang, Hongwei Hou, Jinghong Li.

What is the DOI of this paper?

10.1016/j.addr.2026.115775, permanently at https://doi.org/10.1016/j.addr.2026.115775. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.